Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
Cancer Cell|July 5, 2011
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesisCyril Quivoron, Lucile Couronné, Véronique Della Valle, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Oncotarget|March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancersLuc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Demographic Analysis of Cancer Research Priorities and Treatment CorrelationsDenis Horgan, Marc Van den Bulcke, Umberto Malapelle, et al.
Blood|March 28, 2019
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosumAlain Sarasin, Samuel Quentin, Nathalie Droin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back doorLoic Verlingue, Antoine Hollebecque, Ludovic Lacroix, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 8, 2019
Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropeniaLaurence Duplomb, Julie Rivière, Gaëtan Jego, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
Cancer Cell|July 5, 2011
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesisCyril Quivoron, Lucile Couronné, Véronique Della Valle, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Oncotarget|March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancersLuc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Demographic Analysis of Cancer Research Priorities and Treatment CorrelationsDenis Horgan, Marc Van den Bulcke, Umberto Malapelle, et al.
Blood|March 28, 2019
Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosumAlain Sarasin, Samuel Quentin, Nathalie Droin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back doorLoic Verlingue, Antoine Hollebecque, Ludovic Lacroix, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 8, 2019
Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropeniaLaurence Duplomb, Julie Rivière, Gaëtan Jego, et al.
Pageof 28